Download Files:
Products Details
Product Description
– LG308 is a novel synthetic compound with antimicrotubule activity. LG308 induces mitotic phase arrest and inhibits G2/M progression significantly which is associated with the upregulation of cyclin B1 and mitotic marker MPM-2 and the dephosphorylation of cdc2. LG308 also induces apoptosis and cell death. LG308 significantly suppresses tumor growth. LG308 with antimitotic activity has the potential for the research of prostate cancer[1].
Web ID
– HY-143660
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C19H17FN2O
References
– [1]Qin M, et al. LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity. J Pharmacol Exp Ther. 2015;355(3):473-483.
CAS Number
– 1428341-65-4
Molecular Weight
– 308.35
SMILES
– FC1=CC=CC2=C1NC3=C2CCN(C(CC4=CC=CC=C4)=O)C3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Apoptosis;Microtubule/Tubulin
Pathway
– Apoptosis;Cell Cycle/DNA Damage;Cytoskeleton
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
